By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The discipline of small robotics known as “microbotics” (or “microrobotics”) focuses on mobile robots, especially those with typical dimensions less than 1 mm. Microrobots can perform microscale activities like medication delivery, cell manipulation, microassembly, and biosensing under manual control.
The Global Micro Robots market size will be a small subset of the cancer treatment market as well as industrial automation and micromanufacturing market.
Environmental inspection and infrastructure monitoring will contribute to less than 25% of overall market size by 2030.
The biggest opportunity for micro-robots lies in the medical industry. Microrobots can overcome the blood-brain barrier, allowing for new research and development options in the fight against cancer.
Medical science has faced limitations in treating diseases that impact the brain, such as cancer and neurological disorders, and has been hampered by challenges moving molecules over the blood-brain barrier.
The microrobots may help deliver high therapeutic doses of anti-cancer medications to the brain without exposing healthy tissues to unbearable levels of the chemicals if they are successfully translated to humans.
The pipeline inspection market worth more than $15 Billion per annum has witnessed several new developments and cutting edge innovation in recent years and micro robots can play a vital role in it.
Stringent regulations mandating regular pipeline inspections and Increasing pipeline infrastructure globally are the key growth drivers.
The $500 Billion consumer electronics market has seen growing miniaturization which necessitates the use of smaller robots.
Global medical devices market has witnessed growing demand for wearable electronics and wireless medical devices,which require micromachined components for minimally invasive surgical tools and drug delivery systems.
Microrobots can overcome the blood-brain barrier, allowing for new research and development options in the fight against cancer. Microrobots that can carry therapeutic payloads across the blood-brain barrier have been developed by researchers. The scientists’ microrobots were modeled after neutrophil white blood cells and were propelled to their targets in the brain by rotating magnetic fields. Approaches to treating diseases that impact the brain, such as cancer and neurological disorders, have been hampered by challenges moving molecules over the blood-brain barrier.
One area of research involves cell-based microrobots, but they have been eliminated due to immune responses that they prompted. The drug-loaded nanogels moved through mice’s bloodstream and into their brains as part of a neutrophil, avoiding the immunological reactions that would have limited the utility of other microbots. The researchers were able to regulate the movement of the nanobots due to the usage of magnetic nanogels.
The scientists used a spinning magnetic field to actively direct the nanobots toward the target rather than waiting for them to passively approach the brain. The method prevented the growth of tumour cells more successfully than a conventional medication injection. The microrobots may help deliver high therapeutic doses of anti-cancer medications to the brain without exposing healthy tissues to unbearable levels of the chemicals if they are successfully translated to humans.
